- Home
- INSE vs LYEL Comparison
INSE vs LYEL Comparison
Compare INSE & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSE
- LYEL
- Stock Information
- Founded
- INSE 2002
- LYEL 2018
- Country
- INSE United States
- LYEL United States
- Employees
- INSE N/A
- LYEL N/A
- Industry
- INSE Computer Software: Prepackaged Software
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- INSE Technology
- LYEL Health Care
- Exchange
- INSE Nasdaq
- LYEL Nasdaq
- Market Cap
- INSE 222.5M
- LYEL 207.7M
- IPO Year
- INSE N/A
- LYEL 2021
- Fundamental
- Price
- INSE $6.90
- LYEL $0.47
- Analyst Decision
- INSE Buy
- LYEL Sell
- Analyst Count
- INSE 5
- LYEL 2
- Target Price
- INSE $14.60
- LYEL $1.00
- AVG Volume (30 Days)
- INSE 138.2K
- LYEL 814.6K
- Earning Date
- INSE 03-17-2025
- LYEL 05-05-2025
- Dividend Yield
- INSE N/A
- LYEL N/A
- EPS Growth
- INSE 825.00
- LYEL N/A
- EPS
- INSE 2.22
- LYEL N/A
- Revenue
- INSE $297,100,000.00
- LYEL $61,000.00
- Revenue This Year
- INSE $5.48
- LYEL N/A
- Revenue Next Year
- INSE $3.25
- LYEL N/A
- P/E Ratio
- INSE $3.91
- LYEL N/A
- Revenue Growth
- INSE N/A
- LYEL N/A
- 52 Week Low
- INSE $7.51
- LYEL $0.46
- 52 Week High
- INSE $11.61
- LYEL $3.15
- Technical
- Relative Strength Index (RSI)
- INSE 28.96
- LYEL 37.44
- Support Level
- INSE $8.11
- LYEL $0.53
- Resistance Level
- INSE $8.81
- LYEL $0.63
- Average True Range (ATR)
- INSE 0.48
- LYEL 0.06
- MACD
- INSE -0.11
- LYEL -0.01
- Stochastic Oscillator
- INSE 1.77
- LYEL 9.18
About INSE Inspired Entertainment Inc.
Inspired Entertainment Inc is a gaming technology company based in the United States. Its core business involves the development of Virtual Sports and Server-Based Gaming systems with associated terminals and digital content to regulate betting, gaming, and lottery operators around the world. It operates through four segments namely Gaming; Virtual Sports; Interactive and Leisure. The company generates maximum revenue from the Gaming segment. Its Gaming segment supplies gaming terminals as well as gaming software and games for the terminals provided to betting offices, casinos, gaming halls, and high street adult gaming centers. Geographically, it derives a majority of revenue from the UK.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.